Medipal : Notice of Dividend Increase by Consolidated Subsidiary PALTAC CORPORATION

bf819b41-a798-45f5-9757-f7e4bcf46d4d.pdf

April 28, 2016 MEDIPAL HOLDINGS CORPORATION

Representative: Shuichi Watanabe, Representative Director, President and CEO Code number: 7459 (1st Section, Tokyo Stock Exchange)

Contact: Mamoru Tsuchishio, Manager of Corporate Communications Department

Tel: [phone]

Notice of Revision of Year-End Dividend Forecast

At a meeting of the Board of Directors on April 28, 2016, MEDIPAL HOLDINGS CORPORATION ("MEDIPAL") decided to revise the forecast for the year-end dividend per share for the fiscal year ended March 31, 2016, as summarized below.

1. Reason for Revision of the Dividend Forecast

   MEDIPAL considers returns to shareholders one of its highest management priorities. The Company's basic policy for distribution of profits is to provide dividends that are linked to profits from business activities, while securing the necessary internal reserves to strengthen its financial position and aggressively expand its business.

   MEDIPAL aims to maintain stable dividends, with a target consolidated payout ratio of 25 percent. In consideration of results for the fiscal year as well as other factors, MEDIPAL has decided to revise the forecast for the year-end dividend for the fiscal year ended March 31, 2016 to ¥15 per share, an increase of ¥2 from the previous forecast.

   As a result, total dividends for the fiscal year will be ¥28 per share, including the interim dividend of ¥13 that was already paid.

2. Details of the Revision

Dividends per Share (Yen)
Interim	Year-End	Full-Year Total
Previous forecast (October 30, 2015)	13.00	26.00
Revised forecast	15.00	28.00
Year ended March 31, 2016 (actual)	13.00
Year ended March 31, 2015 (actual)	12.00	12.00	24.00

Note: The above forecast is based on information available as of the date of this announcement. Future events may cause actual dividends to differ from the forecast.

# # #